COCP
NASDAQ · Pharmaceuticals
Cocrystal Pharma Inc
$1.05
-0.01 (-0.94%)
Open$1.07
Previous Close$1.06
Day High$1.08
Day Low$1.03
52W High$2.67
52W Low$0.86
Volume—
Avg Volume85.5K
Market Cap13.72M
P/E Ratio—
EPS$-0.73
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+2,559.0% upside
Current
$1.05
$1.05
Target
$27.92
$27.92
$19.61
$27.92 avg
$38.36
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.74M | 2.80M | 3.00M |
| Net Income | 504.5K | 668.5K | 544.9K |
| Profit Margin | 18.4% | 23.9% | 18.1% |
| EBITDA | 921.2K | 997.7K | 969.2K |
| Free Cash Flow | 728.8K | 746.2K | 561.0K |
| Rev Growth | +19.3% | -9.2% | +14.0% |
| Debt/Equity | 0.92 | 0.92 | 0.80 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,114.20 | +0.64% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $240.15 | +0.45% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $121.17 | +1.31% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.09 | -2.55% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.15 | +1.70% | 12.5 | 33.00B |